Skip to main content

Table 4 Previously published cases treated with RTX for severe refractory HSP

From: Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature

Authors

Year

HSP patients

Donnithorne et el. [15]

2009

3 children ages 17 (male), 14 (male), 10 (female) years old with severe chronic refractory HSP

Pillebout et al. [38]

2011

22-year-old male with severe recurrent skin manifestations and nephritis in biopsy (RTX as only immunomodulation)

Kostik et al. [39]

2013

7-year-old female with severe relapsing HSP with initial response followed by failure 2.5 years later

Tosounindou et al. [40]

2013

61-year-old female with intractable GI manifestations that required repeated courses of RTX to maintain remission

El-Husseini et al. [41]

2013

27-year-old male with drug-induced HSPN

Ishiguro et al. [42]

2013

68-year-old female with refractory purpura nephritis

Pindi Sala [43]

2014

49-year-old female with CS dependent HSP

Bellan et al. [16]

2016

57-year-old female with recurrent purpura and proteinuria refractory to CTX and CS

  1. CS corticosteroid, GI gastrointestinal, HSP Henoch-Schonlein purpura, RTX rituximab